No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Asparaginase / administration & dosage
-
Asparaginase / adverse effects
-
Bone Marrow / drug effects
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Cytarabine / administration & dosage
-
Cytarabine / adverse effects
-
Daunorubicin / administration & dosage
-
Daunorubicin / adverse effects
-
Drug Evaluation
-
Humans
-
Middle Aged
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
-
Prednisolone / administration & dosage
-
Prednisolone / adverse effects
-
Recurrence
-
Remission Induction
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
Substances
-
Cytarabine
-
Vincristine
-
Cyclophosphamide
-
Prednisolone
-
Asparaginase
-
Daunorubicin
Supplementary concepts
-
LOP protocol
-
RACOP protocol